stockrowMerit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024.
- Revenue
- +8.35%
- EPS
- +50.5%
- Free cash flow
- +50.2%
- Total debt
- +0.61%
Quarter to September 2026, against a year earlier
Follow MMSI
Alert me
Merit Medical Systems, Inc. (MMSI) Revenue
Merit Medical Systems, Inc.'s revenue for fiscal 2025 was $1.5B, up 11.8% from $1.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.6B. Over the past ten years it has ranged from $542.1M (fiscal 2015) to $1.5B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Merit Medical Systems, Inc. ranks 19th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.5B | 11.75% |
| FY2024 | $1.4B | 7.89% |
| FY2023 | $1.3B | 9.24% |
| FY2022 | $1.2B | 7.09% |
| FY2021 | $1.1B | 11.50% |
| FY2020 | $963.9M | (3.11%) |
| FY2019 | $994.9M | 12.70% |
| FY2018 | $882.8M | 21.28% |
| FY2017 | $727.9M | 20.54% |
| FY2016 | $603.8M | 11.38% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $416.2M | (0.62%) |
| Jun 2026 | $418.8M | 9.68% |
| Mar 2026 | $381.9M | (3.06%) |
| Dec 2025 | $393.9M | 2.55% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $5.4B |
| MMED MiniMed Group, Inc. compare | $3.0B |
| NVST Envista Holdings Corporation compare | $2.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| MMSI Merit Medical Systems, Inc. | $1.6B |
| STVN Stevanato Group S.p.A. compare | $1.4B |
| ATRC AtriCure, Inc. compare | $589.8M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MMSI
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement